These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8110560)

  • 21. Malignant hyperthermia: slow sodium current in cultured human muscle cells.
    Wieland SJ; Fletcher JE; Rosenberg H; Gong QH
    Am J Physiol; 1989 Oct; 257(4 Pt 1):C759-65. PubMed ID: 2552820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro diagnosis of susceptibility to malignant hyperthermia: evaluation of tests with halothane-caffeine, potassium chloride, suxamethonium and caffeine-suxamethonium.
    Ording H; Skovgaard LT
    Acta Anaesthesiol Scand; 1987 Jul; 31(5):462-5. PubMed ID: 3630591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroleptic malignant syndrome and malignant hyperthermia. In vitro comparison with halothane and caffeine contracture tests.
    Krivosic-Horber R; Adnet P; Guevart E; Theunynck D; Lestavel P
    Br J Anaesth; 1987 Dec; 59(12):1554-6. PubMed ID: 3426910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients].
    Ben-Abraham R; Krivosic-Horber RM; Haudcoeur G; Perel A; Adnet PJ
    Harefuah; 1997 Jun; 132(12):839-41, 911. PubMed ID: 9264187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro contracture testing for determination of susceptibility to malignant hyperthermia: a methodologic update.
    Iaizzo PA; Wedel DJ; Gallagher WJ
    Mayo Clin Proc; 1991 Oct; 66(10):998-1004. PubMed ID: 1833602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro contraction test for malignant hyperthermia in patients with unexplained recurrent rhabdomyolysis.
    Poels PJ; Joosten EM; Sengers RC; Stadhouders AM; Veerkamp JH; Benders AA
    J Neurol Sci; 1991 Sep; 105(1):67-72. PubMed ID: 1795172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The action of ketamine on muscle contractile behavior. In vitro studies on the musculature of subjects susceptible to malignant hyperthermia].
    Hackl W; Winkler M; Mauritz W; Steinbereithner K
    Anaesthesist; 1989 Dec; 38(12):681-5. PubMed ID: 2619030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group.
    Br J Anaesth; 1984 Nov; 56(11):1267-9. PubMed ID: 6487446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ryanodine contracture: a potentially specific in vitro diagnostic test for malignant hyperthermia.
    Hopkins PM; Ellis FR; Halsall PJ
    Br J Anaesth; 1991 May; 66(5):611-3. PubMed ID: 2031823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vitro contracture testing for susceptibility to malignant hyperthermia: can halothane be replaced?
    Metterlein T; Schuster F; Kranke P; Roewer N; Anetseder M
    Eur J Anaesthesiol; 2011 Apr; 28(4):251-5. PubMed ID: 20827211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is there a link between exertional heat stroke and susceptibility to malignant hyperthermia?
    Sagui E; Montigon C; Abriat A; Jouvion A; Duron-Martinaud S; Canini F; Zagnoli F; Bendahan D; Figarella-Branger D; Brégigeon M; Brosset C
    PLoS One; 2015; 10(8):e0135496. PubMed ID: 26258863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of propranolol on the in vitro response to caffeine and halothane in malignant hyperthermia-susceptible muscle.
    Ording H
    Acta Anaesthesiol Scand; 1989 Jul; 33(5):405-8. PubMed ID: 2800978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is the "K-type" caffeine-halothane responder susceptible to malignant hyperthermia?
    Ellis FR; Halsall PJ; Hopkins PM
    Br J Anaesth; 1992 Nov; 69(5):468-70. PubMed ID: 1467078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Static v. dynamic tests in the in vitro diagnosis of malignant hyperthermia susceptibility.
    Ranklev E; Fletcher R; Blomquist S
    Br J Anaesth; 1986 Jun; 58(6):646-8. PubMed ID: 3707802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnosis of susceptibility to malignant hyperthermia using the in vitro contracture test].
    Klein W; Spiess-Kiefer C; Küther G; Pongratz D; Lehmann-Horn F
    Anaesthesist; 1987 Dec; 36(12):685-91. PubMed ID: 2830805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the caffeine skinned fibre tension (CSFT) test with the caffeine-halothane contracture (CHC) test in the diagnosis of malignant hyperthermia.
    Britt BA; Frodis W; Scott E; Clements MJ; Endrenyi L
    Can Anaesth Soc J; 1982 Nov; 29(6):550-62. PubMed ID: 7139394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Na(+)-Ca2+ exchange influences halothane and caffeine contractures of malignant hyperthermic skeletal muscle.
    Williams JH; Lee JC; Holland M
    Res Commun Chem Pathol Pharmacol; 1992 Aug; 77(2):253-6. PubMed ID: 1439194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant hyperthermia and related neuromuscular diseases: caffeine contracture of the skinned muscle fibers.
    Takagi A; Sunohara N; Ishihara T; Nonaka I; Sugita H
    Muscle Nerve; 1983 Sep; 6(7):510-4. PubMed ID: 6633564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Caffeine skinned fiber tension test: application to the diagnosis of susceptibility to malignant hyperthermia].
    Adnet P; Börtlein ML; Tavernier B; Nivoche Y; Etchrivi T; Krivosic-Horber R; Haudecoeur G
    Ann Fr Anesth Reanim; 1999 Jun; 18(6):624-30. PubMed ID: 10464528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age, fiber type composition and in vitro contracture responses in human malignant hyperthermia.
    Ording H; Hansen U; Skovgaard LT
    Acta Anaesthesiol Scand; 1988 Feb; 32(2):121-4. PubMed ID: 3348072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.